Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Lise Balteskard

52 publications found

Original articles

Olsen F, Uleberg B, Jacobsen BK, Heuch I, Tande PM, Bugge E, Balteskard L (2022)
Socioeconomic and geographic differences in ablation of atrial fibrillation in Norway - a national cohort study
BMC Public Health, 22 (1), 303
DOI 10.1186/s12889-022-12628-9, PubMed 35164725

Olsen F, Jacobsen BK, Heuch I, Tveit KM, Balteskard L (2021)
Equitable access to cancer patient pathways in Norway - a national registry-based study
BMC Health Serv Res, 21 (1), 1272
DOI 10.1186/s12913-021-07250-1, PubMed 34823515

Olsen F, Balteskard L, Uleberg B, Jacobsen BK, Heuch I, Moen A (2021)
Impact of parents' education on variation in hospital admissions for children: a population-based cohort study
BMJ Open, 11 (6), e046656
DOI 10.1136/bmjopen-2020-046656, PubMed 34158300

Ingebrigtsen T, Balteskard L, Guldhaugen KA, Kloster R, Uleberg B, Grotle M, Solberg TK (2020)
Treatment rates for lumbar spine surgery in Norway and Northern Norway Regional Health Authority 2014-18
Tidsskr Nor Laegeforen, 140 (17)
DOI 10.4045/tidsskr.20.0313, PubMed 33231397

Heiberg IH, Nesvåg R, Balteskard L, Bramness JG, Hultman CM, Naess Ø, Reichborn-Kjennerud T, Ystrom E, Jacobsen BK, Høye A (2020)
Diagnostic tests and treatment procedures performed prior to cardiovascular death in individuals with severe mental illness
Acta Psychiatr Scand, 141 (5), 439-451
DOI 10.1111/acps.13157, PubMed 32022895

Heiberg IH, Jacobsen BK, Balteskard L, Bramness JG, Naess Ø, Ystrom E, Reichborn-Kjennerud T, Hultman CM, Nesvåg R, Høye A (2019)
Undiagnosed cardiovascular disease prior to cardiovascular death in individuals with severe mental illness
Acta Psychiatr Scand, 139 (6), 558-571
DOI 10.1111/acps.13017, PubMed 30844079

Norum J, Balteskard L, Thomsen MW, Kvernmo HD (2018)
Wrist malpractice claims in Northern Norway 2005-2014. Lessons to be learned
Int J Circumpolar Health, 77 (1), 1483690
DOI 10.1080/22423982.2018.1483690, PubMed 29912658

Kvernmo HD, Otterdal P, Balteskard L (2017)
Treatment of wrist fracture 2009-14
Tidsskr. Nor. Laegeforen., 137 (19), 1501-1506

Kvernmo HD, Otterdal P, Balteskard L (2017)
Treatment of wrist fractures 2009-14
Tidsskr Nor Laegeforen, 137 (19)
DOI 10.4045/tidsskr.17.0065, PubMed 29043745

Norum J, Hansen TM, Hovland A, Balteskard L, Haug B, Olsen F, Trovik T (2017)
Calculating the 30-day Survival Rate in Acute Myocardial Infarction: Should we Use the Treatment Chain or the Hospital Catchment Model?
Heart Int, 12 (1)
DOI 10.5301/heartint.5000238, PubMed 30263101

Norum J, Hovland A, Balteskard L, Trovik T, Haug B, Hansen FH, Alterskjær S, Madsen P, Olsen F (2017)
Treatment of acute myocardial infarction in the sub-arctic region of Norway. Do we offer an equal quality of care?
Int J Circumpolar Health, 76 (1), 1391651
DOI 10.1080/22423982.2017.1391651, PubMed 29069984

Kristiansen JA, Balteskard L, Slettebø H, Nygaard ØP, Lied B, Kolstad F, Solberg TK (2016)
The use of surgery for cervical degenerative disease in Norway in the period 2008-2014 : A population-based study of 6511 procedures
Acta Neurochir (Wien), 158 (5), 969-74
DOI 10.1007/s00701-016-2760-1, PubMed 26983821

Olsen F, Uleberg B, Jacobsen BK, Balteskard L (2016)
Norwegian patients with colon cancer start their adjuvant therapy too late
Tidsskr Nor Laegeforen, 136 (1), 27-31
DOI 10.4045/tidsskr.14.0812, PubMed 26757656

Leon O, Guren M, Hagberg O, Glimelius B, Dahl O, Havsteen H, Naucler G, Svensson C, Tveit KM, Jakobsen A, Pfeiffer P, Wanderås E, Ekman T, Lindh B, Balteskard L, Frykholm G, Johnsson A (2014)
Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines
Radiother Oncol, 113 (3), 352-8
DOI 10.1016/j.radonc.2014.10.002, PubMed 25499203

Bentzen AG, Guren MG, Vonen B, Wanderås EH, Frykholm G, Wilsgaard T, Dahl O, Balteskard L (2013)
Faecal incontinence after chemoradiotherapy in anal cancer survivors: long-term results of a national cohort
Radiother Oncol, 108 (1), 55-60
DOI 10.1016/j.radonc.2013.05.037, PubMed 23891095

Bentzen AG, Balteskard L, Wanderås EH, Frykholm G, Wilsgaard T, Dahl O, Guren MG (2013)
Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors
Acta Oncol, 52 (4), 736-44
DOI 10.3109/0284186X.2013.770599, PubMed 23438358

Bentzen AG, Guren MG, Wanderås EH, Frykholm G, Tveit KM, Wilsgaard T, Dahl O, Balteskard L (2012)
Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort
Int J Radiat Oncol Biol Phys, 83 (2), e173-80
DOI 10.1016/j.ijrobp.2011.12.062, PubMed 22436791

Myklebust MP, Fluge Ø, Immervoll H, Skarstein A, Balteskard L, Bruland O, Dahl O (2012)
Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients
Br J Cancer, 106 (4), 756-62
DOI 10.1038/bjc.2011.548, PubMed 22333708

Myklebust MP, Bruland O, Fluge Ø, Skarstein A, Balteskard L, Dahl O (2011)
MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer
Br J Cancer, 105 (11), 1719-25
DOI 10.1038/bjc.2011.457, PubMed 22045185

Emaus N, Heiberg I, Ahmed LA, Balteskard L, Jacobsen BK, Magnus T, Olsen LR, Ytterstad B (2011)
Methodological challenges in hip fracture registration: the Harstad Injury Registry
Int J Inj Contr Saf Promot, 18 (2), 135-42
DOI 10.1080/17457300.2010.540331, PubMed 21432705

Emaus N, Olsen LR, Ahmed LA, Balteskard L, Jacobsen BK, Magnus T, Ytterstad B (2011)
Hip fractures in a city in Northern Norway over 15 years: time trends, seasonal variation and mortality : the Harstad Injury Prevention Study
Osteoporos Int, 22 (10), 2603-10
DOI 10.1007/s00198-010-1485-x, PubMed 21249333

Bruheim K, Tveit KM, Skovlund E, Balteskard L, Carlsen E, Fosså SD, Guren MG (2010)
Sexual function in females after radiotherapy for rectal cancer
Acta Oncol, 49 (6), 826-32
DOI 10.3109/0284186X.2010.486411, PubMed 20615170

Bruheim K, Guren MG, Dahl AA, Skovlund E, Balteskard L, Carlsen E, Fosså SD, Tveit KM (2009)
Sexual function in males after radiotherapy for rectal cancer
Int J Radiat Oncol Biol Phys, 76 (4), 1012-7
DOI 10.1016/j.ijrobp.2009.03.075, PubMed 19880263

Hansen MH, Balteskard L, Dørum LM, Eriksen MT, Vonen B, Norwegian Colorectal Cancer Group (2009)
Locally recurrent rectal cancer in Norway
Br J Surg, 96 (10), 1176-82
DOI 10.1002/bjs.6699, PubMed 19787766

Nieder C, Pawinski A, Balteskard L (2009)
Colorectal cancer metastatic to the brain: time trends in presentation and outcome
Oncology, 76 (5), 369-74
DOI 10.1159/000210026, PubMed 19321946

Bruland O, Fluge O, Immervoll H, Balteskard L, Myklebust M, Skarstein A, Dahl O (2008)
Gene expression reveals two distinct groups of anal carcinomas with clinical implications
Br J Cancer, 98 (7), 1264-73
DOI 10.1038/sj.bjc.6604285, PubMed 18349847

Qvortrup C, Yilmaz M, Ogreid D, Berglund A, Balteskard L, Ploen J, Fokstuen T, Starkhammar H, Sørbye H, Tveit K, Pfeiffer P (2008)
Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil
Ann Oncol, 19 (6), 1154-9
DOI 10.1093/annonc/mdn002, PubMed 18281265

Glimelius B, Sørbye H, Balteskard L, Byström P, Pfeiffer P, Tveit K, Heikkilä R, Keldsen N, Albertsson M, Starkhammar H, Garmo H, Berglund A (2008)
A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer
Ann Oncol, 19 (5), 909-14
DOI 10.1093/annonc/mdm588, PubMed 18209013

Bentzen AG, Vonen B, Wiig JN, Balteskard L (2007)
[Recurrence of rectal cancer--treatment in Norwegian hospitals]
Tidsskr Nor Laegeforen, 127 (23), 3102-5
PubMed 18049504

Sørlie T, Rosenvinge JH, Bremnes R, Balteskard L, Dahl AA, Klepp O, Fosså SD (2006)
Management satisfaction in survivors of testicular cancer
Anticancer Res, 26 (2B), 1463-9
PubMed 16619559

Nilsson S, Larsen RH, Fosså SD, Balteskard L, Borch KW, Westlin JE, Salberg G, Bruland OS (2005)
First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases
Clin Cancer Res, 11 (12), 4451-9
DOI 10.1158/1078-0432.CCR-04-2244, PubMed 15958630

Norum J, Grev A, Moen MA, Balteskard L, Holthe K (2003)
Information and communication technology (ICT) in oncology. Patients' and relatives' experiences and suggestions
Support Care Cancer, 11 (5), 286-93
DOI 10.1007/s00520-002-0437-1, PubMed 12690539

Norum J, Balteskard L, Edna TH, Laino R, Wählby L, Rønning G (2002)
Ralitrexed (Tomudex) or Nordic-FLv regimen in metastatic colorectal cancer: a randomized phase II study focusing on quality of life, patients' preferences and health economics
J Chemother, 14 (3), 301-8
DOI 10.1179/joc.2002.14.3.301, PubMed 12120887

Balteskard L, Rinde E (1999)
Medical diagnosis in the internet age
Lancet, 354 S, 14

Balteskard L, Rinde E (1999)
Medical diagnosis in the Internet age
Lancet, 354 Suppl, SIV14
DOI 10.1016/s0140-6736(99)90357-4, PubMed 10691424

Balteskard L, Unneberg K, Mjaaland M, Jenssen TG, Revhaug A (1998)
Growth hormone and insulinlike growth factor 1 promote intestinal uptake and hepatic release of glutamine in sepsis
Ann Surg, 228 (1), 131-9
DOI 10.1097/00000658-199807000-00019, PubMed 9671077

Balteskard L, Unneberg K, Mjaaland M, Sager G, Jenssen TG, Revhaug A (1998)
Treatment with growth hormone and insulin-like growth factor-1 in septicemia: effects on carbohydrate metabolism
Eur Surg Res, 30 (2), 79-94
DOI 10.1159/000008562, PubMed 9565741

Balteskard L, Unneberg K, Halvorsen D, Hansen JB, Revhaug A (1998)
Effects of insulin-like growth factor 1 on neutrophil and monocyte functions in normal and septic states
JPEN J Parenter Enteral Nutr, 22 (3), 127-35
DOI 10.1177/0148607198022003127, PubMed 9586789

Unneberg K, Balteskard L, Mjaaland M, Sager G, Revhaug A (1997)
Growth hormone increases and IGF-1 reduces the response to Escherichia coli infusion in injured pigs
Eur J Surg, 163 (10), 779-88
PubMed 9373230

Unneberg K, Mjaaland M, Balteskard L, Jenssen TG, Bjøro T, Revhaug A (1997)
Both growth hormone and exogenous glutamine increase gastrointestinal glutamine uptake in trauma
Ann Surg, 225 (1), 97-102
DOI 10.1097/00000658-199701000-00011, PubMed 8998125

Balteskard L, Unneberg K, Halvorsen D, Ytrebø LM, Waage A, Sjursen H, Revhaug A (1997)
The influence of growth hormone on tumour necrosis factor and neutrophil leukocyte function in sepsis
Scand J Infect Dis, 29 (4), 393-9
DOI 10.3109/00365549709011837, PubMed 9360256

Unneberg K, Balteskard L, Mjaaland M, Revhaug A (1996)
Growth hormone impaired compensation of hemorrhagic shock after trauma and sepsis in swine
J Trauma, 41 (5), 775-80
DOI 10.1097/00005373-199611000-00002, PubMed 8913203

Unneberg K, Mjaaland M, Balteskard L, Jenssen TG, Revhaug A (1996)
Growth hormone pre-treatment combined with exogenous glutamine induced a postoperative shift from glucose to glutamine consumption in the gastrointestinal tract
Clin Nutr, 15 (4), 165-70
DOI 10.1016/s0261-5614(96)80235-4, PubMed 16844028

Busund R, Balteskard L, Rønning G, Høgåsen K, Revhaug A (1995)
Fatal myocardial depression and circulatory collapse associated with complement activation induced by plasma infusion in severe porcine sepsis
Acta Anaesthesiol Scand, 39 (1), 100-8
DOI 10.1111/j.1399-6576.1995.tb05600.x, PubMed 7725871

Balteskard L, Brox JH, Osterud B (1993)
Thromboxane production in the blood of women increases after menopause whereas tumor necrosis factor is reduced in women compared with men
Atherosclerosis, 102 (1), 91-8
DOI 10.1016/0021-9150(93)90087-b, PubMed 8257457

Busund R, Lindsetmo RO, Balteskard L, Rekvig OP, Revhaug A (1993)
Repeated plasma therapy induces fatal shock in experimental septicemia
Circ Shock, 40 (4), 268-75
PubMed 8375029

Review articles

Sørbye H, Braendengen M, Balteskard L (2008)
[Palliative chemotherapy and radiotherapy for metastatic colorectal cancer]
Tidsskr Nor Laegeforen, 128 (2), 194-7
PubMed 18202732

Balteskard L, Vonen B, Frykholm G, Dahl O, Tveit KM (2007)
[Radiotherapy of rectal cancer]
Tidsskr Nor Laegeforen, 127 (23), 3090-3
PubMed 18049501